Related Experiment Video
Updated: Sep 23, 2025

Investigating Long-Distance Transport of Perfluoroalkyl Acids in Wheat via a Split-Root Exposure Technique
Published on: September 28, 2022
Influence of Perfluoroalkyl Substances on Occurrence of Coronavirus Disease 2019
Zygmunt F Dembek1, Robert A Lordo1
1Battelle Memorial Institute, Columbus, OH 43201, USA.
Insights
Higher polyfluoroalkyl substances (PFAS) blood levels correlate with increased COVID-19 incidence in older populations. Early-life PFAS exposure may lead to long-term health issues, including reduced disease resistance.
Area of Science:
- Environmental Health
- Immunology
- Epidemiology
Background:
- Polyfluoroalkyl substances (PFAS) are linked to immunosuppression and reduced vaccine efficacy.
- The association between PFAS exposure and COVID-19 risk, particularly across different age groups, requires further investigation.
Purpose of the Study:
- To examine the relationship between blood PFAS levels and COVID-19 incidence across various age demographics.
- To identify populations with differing PFAS exposure levels and correlate them with COVID-19 occurrence.
Main Methods:
- Literature review of recent PFAS population studies and summarization of age and gender results.
- Acquisition of geographically corresponding COVID-19 incidence data for North Carolina, Ohio, and New Jersey.
- Analysis of Centers for Disease Control and Prevention COVID-19 databases for national incidence data by age group.
Main Results:
- A general trend of higher PFAS blood levels was observed in older age groups.
- Younger age groups exhibited fewer COVID-19 cases.
- Highest levels of both PFAS exposure and COVID-19 incidence were found in the oldest populations.
Conclusions:
- While causality is not established, a correlation exists between higher PFAS levels and increased COVID-19 incidence in older individuals.
- PFAS exposure, potentially starting early in life, may contribute to long-term health effects like decreased antibody response and reduced disease resistance.
- Further research is warranted to understand the implications of PFAS exposure on infectious disease susceptibility.
Abstract:
Epidemiologic evidence indicates exposure to polyfluoroalkyl substances (PFAS) influences immunosuppression, with diminished vaccination response. The relationship between PFAS blood levels and coronavirus disease 2019 (COVID-19) occurrence by age warrants further examination. This assessment identified blood PFAS exposure levels in discrete populations. Recent PFAS population studies summarizing age and gender results were identified and included. Geographically corresponding COVID-19 incidence data were determined for selected counties in North Carolina (NC) and Ohio (OH), and the state of New Jersey (NJ). Centers for Disease Control and Prevention COVID-19 databases were accessed for national incidence data by age groupings. We assessed associations between blood PFAS concentrations, COVID-19 incidence rates, and key demographic characteristics, within subpopulations. COVID-19 incidence counts and blood PFAS concentration were obtained for each age group, along with estimated U.S. Census total population. A general trend observed is higher PFAS levels in older age groups. Younger age groups contained fewer COVID-19 cases. Global COVID-19 mortality is highest in elderly populations with hospitalization and death greatly increasing from age 50. PFAS exposures occurring early in life may cause deleterious health effects later in life, including decreased antibody response and reduced disease resistance. Highest levels of both PFAS exposure and COVID-19 were found in the oldest populations. While this does not determine causality, such associations should help promote further study.
More Related Videos
09:04Identifying Per- and Polyfluorinated Chemical Species with a Combined Targeted and Non-Targeted-Screening High-Resolution Mass Spectrometry Workflow
Published on: April 18, 2019
03:53Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023